跳至主要内容
临床试验/NCT00771212
NCT00771212已完成不适用

Observational Study on the Patients With Pain Medications

Johnson & Johnson Taiwan Ltd0 个研究点目标入组 2,636 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,636
主要终点
To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan

研究概览

简要总结

The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.

详细描述

This is a Phase IV, multi-center, observational study to describe the use of pain treatments, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment. The study is conducted in an effort to understand the status of pain control in Taiwan. Currently in Taiwan, there is no approved documentation showing the most effective standard medication for treatment of patients in pain. Observational study with no study medication administered.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatients only
  • Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
  • Patient must have a VAS score >4

排除标准

  • Patients who are receiving any investigational drug during the study
  • Patients with known or suspected psychotic disease or mental retardation.

结局指标

主要结局

To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan

时间窗: 60 days

次要结局

  • Pain Relief Rating Scale(60 days)
  • Global Assessments (Patient/Investigator)(60 days)
  • Sleeping quality Assessment(60 days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验